A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework-Reference-Cited by-同舟云学术

A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit framework

Published:2010-10-26 Issue:11 Volume:19 Page:1172-1180
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Lynd Larry D.,Marra Carlo A.,Najafzadeh Mehdi,Sadatsafavi Mohsen

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.1994/fullpdf

Reference40 articles.

1. Therapeutic usage of the non-steroidal anti-inflammatory drugs;Champion;Med J Aust,1988

2. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use;Laine;Gastroenterology,2003

3. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review;Rostom;Clin Gastroenterol Hepatol,2007

4. Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis;Watson;Arch Intern Med,2000

5. Rofecoxib and the risk of adverse upper gastrointestinal effects;Whitney;J Am Med Assoc,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefit–risk assessment and reporting in clinical trials of chronic pain treatments;Pain;2021-09-09

2. Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France;Clinical Therapeutics;2020-10

3. Benefit-Risk Assessment in Pharmacovigilance;Methods in Pharmacology and Toxicology;2018

4. New Statistical Methods of Combining Results in Comparative Effectiveness Research;Comparative Effectiveness Research in Health Services;2016

5. Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis;BMC Medical Informatics and Decision Making;2015-12